5-(Chlorosulfonyl)-2,3-difluorobenzoyl chloride

Catalog No.: 
ACTMXB268
CAS No.: 
1594453-99-2
Molecular Formula: 
C7H2Cl2F2O3S
Molecular Weight: 
275.06
5-(Chlorosulfonyl)-2,3-difluorobenzoyl chloride structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
250mg95%$287.00InquiryInquiry
1g95%$833.00InquiryInquiry
5g95%$4082.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name5-(Chlorosulfonyl)-2,3-difluorobenzoyl chloride
IUPAC Name5-(chlorosulfonyl)-2,3-difluorobenzoyl chloride
MDL No.MFCD31420891
Molecular FormulaC7H2Cl2F2O3S
Molecular Weight275.06
SMILESO=C(Cl)C1=CC(S(=O)(Cl)=O)=CC(F)=C1F
InChI KeySXLDQHIYJVPZEJ-UHFFFAOYSA-N
SynonymBenzoyl chloride, 5-(chlorosulfonyl)-2,3-difluoro-
CAS No.1594453-99-2

Safety Data

Pictogram
Corrosive
Signal Word
Gefahr
Hazard Statement(s)
H290-H314
Precautionary Statement(s)
P234-P260-P264-P280-P301+P330+P331-P303+P361+P353-P304+P340+P310-P305+P351+P338+P310-P363-P390-P405-P406-P501

Synthetic Route by SureRoute

1. ACTMXB268 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACTMXB268 route product structure diagram
    ACTMXB2681594453-99-2
Inquiry

2. ACTMXB268 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACTMXB268 route product structure diagram
    ACTMXB2681594453-99-2
Inquiry

3. ACTMXB268 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACTMXB268 route product structure diagram
    ACTMXB2681594453-99-2
Inquiry

Comments (0)